Cytyc's ThinPrep takes over in Ireland:
This article was originally published in Clinica
Cytyc has become the exclusive supplier of liquid-based cytology to Ireland's laboratories, after the company's Irish distributor Screenlink clinched a deal with the remaining two laboratories that have yet to be converted to Cytyc's ThinPrep Pap test. Around 250,000 cervical cancer tests are performed in Ireland each year. Currently, 150,000 of these tests are carried out on the Marlborough, Massachusetts company's ThinPrep system. The remaining labs, based in Cork and Galway, are expected to undergo the conversion to ThinPrep in the next few months.
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.